Early-Stage Investigator Lecture (ESIL)

2020 Awardee

November 17, 2020, 11:00 a.m. ET

Image of Dr. Marcus
Julia Marcus, Ph.D., M.P.H.

Harvard Medical School and Harvard Pilgrim Health Care Institute

*A recording of this webinar will be available approximately one week after the session.

Lecture Title: Scaling up HIV Pre-Exposure Prophylaxis to End the HIV Epidemic

About This Lecture

Read our Q&A with Dr. Marcus to learn more about her work, her perspective on the challenges facing HIV prevention research, and her approach to public health.

Daily oral HIV pre-exposure prophylaxis, or PrEP, is up to 99% effective in preventing HIV transmission and has been approved by the Food and Drug Administration since 2012. However, of the 1.2 million Americans who could benefit from PrEP, less than 20% have used it, and there are substantial racial and ethnic disparities in uptake. Scale-up of PrEP is a critical component of the federal initiative to end the HIV epidemic, but achieving this goal will require effective strategies to improve PrEP implementation. In this presentation, Dr. Marcus will discuss her research on strategies to improve PrEP uptake, including the use of electronic health records to help health care providers identify patients who may benefit from PrEP.

About Julia Marcus

Julia Marcus, Ph.D., M.P.H. is an infectious disease epidemiologist and Associate Professor in the Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute, as well as Adjunct Faculty at The Fenway Institute. Her research focuses on HIV, hepatitis C, and other sexually transmitted infections, with a primary interest in the implementation of PrEP for HIV prevention. Her studies have leveraged data from electronic health records to identify patients who may benefit from PrEP, characterize PrEP uptake and continuation, and document clinical outcomes among PrEP users in real-world health care settings. Dr. Marcus’ work has been funded by several NIH institutes, including the National Institute of Allergy and Infectious Diseases, the National Institute of Mental Health, and the National Institute on Minority Health and Health Disparities.

Last updated on October 21, 2020